Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Fudan University

28 clinical trials · 28 recruiting · OTHER

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by Fudan University

RECRUITINGNCT06966141

A Real World Study of Sacituzumab Govitecan

Clinical Outcomes and Safety of Sacituzumab Govitecan in Metastatic HER-2 negative Breast Cancer Patients

Sponsor: Fudan UniversityEnrolling: 1001 location
Breast Cancer MetastaticTreatment Outcome
RECRUITINGPhase 2NCT07109401

Perioperative Immunotherapy for Resectable Limited-Stage SCLC

For limited-stage small cell lung cancer (SCLC), surgical treatment is recommended for patients with T1-2N0M0 (I-IIA) by guidelines. However, whether perioperative immunotherapy...

Sponsor: Fudan UniversityEnrolling: 371 location
Perioperative ImmunotherapyLimited Stage Lung Small Cell CarcinomaResectable Small Cell Lung Cancer
RECRUITINGPhase 2NCT07451795

SHR-1701 in Combination With Stereotactic Body Radiotherapy in mCRPC

The aim of this study is to evaluate the efficacy of SHR-1701 in combination with SBRT in patients with metastatic castration-resistant prostate cancer. Dr. Yao Zhu from Fudan...

Sponsor: Fudan UniversityEnrolling: 663 locations
Prostate CancermCRPC (Metastatic Castration-resistant Prostate Cancer)
RECRUITINGPhase 2NCT05954429

A Study to Explore the Third-line Treatment of Fruquintinib Combined With Serplulimab in Advanced Non-liver-limited...

The aim of this clinical trial is to learn about efficacy of fruquintinib combined with serplulimab in patients with microsatellite stabilized mCRC who have failed standard...

Sponsor: Fudan UniversityEnrolling: 502 locations
Colorectal Cancer
RECRUITINGPhase 3NCT06250972

Radiotherapy to Patients With CA19-9-elevated Advanced Pancreatic Cancer

The purpose of this study is to evaluate the efficacy of chemotherapy plus radiotherapy to patients with CA19-9-elevated Advanced Pancreatic Cancer who are not refractory to...

Sponsor: Fudan UniversityEnrolling: 2101 location
Pancreatic Adenocarcinoma
RECRUITINGPhase 2 / Phase 3NCT06598033

Vitamin C Plus Cordyceps to Quality of Life in Patients With Terminal Stage Pancreatic Cancer

The purpose of this study is to evaluate the efficacy of vitamin C plus herbal medicine in improving the quality of life for metastatic pancreatic cancer patients who are...

Sponsor: Fudan UniversityEnrolling: 501 location
Pancreatic Cancer
RECRUITINGPhase 2NCT06018896

Vitamin C to Quality of Life in Patients With Terminal Stage Pancreatic Cancer

The purpose of this study is to evaluate the efficacy of vitamin C in improving the quality of life for metastatic pancreatic cancer patients who are resistant to chemotherapy.

Sponsor: Fudan UniversityEnrolling: 201 location
Metastatic Pancreatic CancerTerminal Cancer
RECRUITINGNCT05446545

Bespoke ctDNA Assay for Recurrence and Treatment Response Monitoring in Advanced Epithelial Ovarian Cancer

This prospective observational study is to assess the dynamics of circulating tumor DNA (ctDNA) in patients with advanced epithelial ovarian cancer (EOC) undergoing surgery,...

Sponsor: Fudan UniversityEnrolling: 1391 location
Ovarian Cancer
RECRUITINGNCT06545994

A Prospective Cohort Study on the Serum Kisspeptin Levels Throughout Pregnancy in PCOS

The current study aims to investigate the dynamic serum kisspeptin levels throughout pregnancy and to explore its predictive value for GDM in PCOS.

Sponsor: Fudan UniversityEnrolling: 1801 location
Polycystic Ovary SyndromePregnancy Complications
RECRUITINGPhase 2NCT06965231

Perioperative Toripalimab and Endostatin for Stage II Melanoma: A Phase II Trial

This is a Phase II clinical trial to evaluate the efficacy and safety of perioperative toripalimab (anti-PD-1) combined with recombinant human endostatin (Endostar) as...

Sponsor: Fudan UniversityEnrolling: 584 locations
Melanoma of SkinAcral MelanomaStage II Melanoma
RECRUITINGPhase 4NCT07445022

RWS of Tunlametinib in NRAS-Mutant Advanced Melanoma

This study is a prospective, open-label, multicenter, real-world clinical study to evaluate the efficacy and safety of tunlametinib in patients with NRAS-mutant advanced melanoma...

Sponsor: Fudan UniversityEnrolling: 1101 location
Melanoma Advanced
RECRUITINGPhase 2NCT06341556

A Multicenter, Prospective, Phase II Study of Zanubrutinib for Maintenance in Patients With Mantle Cell Lymphoma

This study aims to evaluate whether maintenance therapy with Zanubrutinib monotherapy could improve the 2-year progression free survival (PFS) of patients with mantle cell...

Sponsor: Fudan UniversityEnrolling: 522 locations
Mantle Cell LymphomaMaintenance Therapy
RECRUITINGPhase 2NCT04512534

Sintilimab Combined With Chidamide in Treating Peripheral T Cell Lymphoma

This is a single-center, single-arm, phase 2 study to evaluate the efficacy and safety of Anti-PD-1 antibody(Sintilimab) plus HDAC inhibitor(Chidamide) in patients with...

Sponsor: Fudan UniversityEnrolling: 511 location
Peripheral T-cell Lymphoma
RECRUITINGPhase 1 / Phase 2NCT06718933

Study of SHR-A1811 Combined With Pyrotinib and Bevacizumab in Advanced Breast Cancer With Brain Metastasis

In phase Ib, our study is aimed to evaluate the safety and tolerance of SHR-A1811 combined with pyrotinib in breast cancer with brain metastasis, and confirm the recommended phase...

Sponsor: Fudan UniversityEnrolling: 741 location
Breast Cancer MetastaticBreast Cancer Brain Metastases
RECRUITINGPhase 2NCT06860490

HAIC Combined with Sintilimab Plus Bevacizumab Biosimilar for Advanced Hepatocellular Carcinoma (TASK-03)

To evaluate HAIC combined with Sintilimab plus bevacizumab biosimilar for advanced hepatocellular carcinoma.

Sponsor: Fudan UniversityEnrolling: 1641 location
Hepatocellular Carcinoma (HCC)
RECRUITINGNCT06934018

Effect of Surgical Margin Width on Recurrence and Survival in Patients With Hepatic Oligometastasis of Colorectal Cancer

The main objective of this study was to evaluate the effect of surgical margin width on the prognosis of patients with hepatic oligometastasis of colorectal cancer by statistical...

Sponsor: Fudan UniversityEnrolling: 1401 location
OncologyTumor Recurrence and Metastasis
RECRUITINGPhase 2NCT06970353

Phase II Trial of Tunlametinib in NRAS-Mutant Advanced Thyroid Cancer

This phase II trial evaluates Tunlametinib (MEK inhibitor) ± PD-1 in NRAS-mutant advanced thyroid cancer. Key Objectives: Assess efficacy (ORR by RECIST v1.1) Evaluate safety...

Sponsor: Fudan UniversityEnrolling: 401 location
Radioactive Iodine-refractory, Differentiated Thyroid Cancer With NRAS MutationAdvanced PDTC or ATC With NRAS Mutation
RECRUITINGPhase 3NCT06554652

Selective Neck Dissection Versus Modified Neck Dissection in PTC

This study is a phase III, randomized controlled, open label non inferiority study. Patients who meet the inclusion criteria are randomly assigned 1:1 to either the experimental...

Sponsor: Fudan UniversityEnrolling: 2501 location
Thyroid Cancer
RECRUITINGNCT06524167

RW Study of Adjuvant Radiotherapy in Locally Advanced Thyroid Cancer

This study is a real-world study to observe the role of adjuvant radiotherapy in locally advanced recurrent high-risk thyroid cancer. The study included thyroid cancer that...

Sponsor: Fudan UniversityEnrolling: 801 location
Thyroid Cancer
RECRUITINGNCT06786169

The Relationship of Psychological Stress With Therapy Efficacy and Prognosis of Gastric Cancer

This is the prospective, observational cohort study (G-Distress) to explore the associations of psychological stress with treatment and prognosis of gastric cancer. The...

Sponsor: Fudan UniversityEnrolling: 6001 location
Gastric Cancer, Gastroesophageal Junction Cancer
RECRUITINGPhase 2NCT05975749

Adjuvant Serplulimab and Trastuzuma and Chemotherapy in Her-2+ Gastric Cancer

The purpose of this study is to find out whether treatment with Serplulimab combined with Trastuzumab and Chemotherapy will improve the survival of gastric cancer patients with...

Sponsor: Fudan UniversityEnrolling: 1141 location
Gastric Cancer
RECRUITINGPhase 2NCT07403136

Vebrekotuzumab ± Anti-PD-1 in Pretreated Advanced ESCC

This study will test a new potential treatment for advanced esophageal squamous cell cancer (ESCC) for patients whose initial treatment has stopped working. Currently, the...

Sponsor: Fudan UniversityEnrolling: 521 location
Esophageal Squamous Cell Carcinoma
RECRUITINGNCT05760391

A Study of IO Plus Radiotherapy in Patients With Advanced ESCC.

This study is a single-arm, prospective, phase II trial for patients with metastatic esophageal squamous cell carcinoma (ESCC) who received immunotherapy plus chemotherapy as the...

Sponsor: Fudan UniversityEnrolling: 1001 location
Metastatic Esophageal Squamous Cell Carcinoma
RECRUITINGPhase 3NCT06964568

CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC

The goal of this clinical trial is to learn if concurrent chemoradiotherapy followed by immunotherapy as maintenance therapy works to treat locally advanced esophageal squamous...

Sponsor: Fudan UniversityEnrolling: 4521 location
Esophageal CarcinomaRadiotherapyImmunotherapy
RECRUITINGNCT05443841

Value of Pleural Lavage Cytology in Resectable Esophageal Carcinoma Eastern Cooperative Thoracic Oncology Projects...

Disease recurrence and metastasis are common after curative treatment for patients with esophageal cancer. Thus, it is important to identify the risk factors to predict disease...

Sponsor: Fudan UniversityEnrolling: 38511 locations
Esophageal Cancer
RECRUITINGNCT06431997

A Study of the Intervention of Time-restricted Eating in High-risk Populations of GDM

This is a randomized controlled trial, aiming to investigate whether a time-restricted eating (TRE) can reduce the incidence of gestational diabetes mellitus (GDM) in high-risk...

Sponsor: Fudan UniversityEnrolling: 2401 location
Gestational Diabetes MellitusDietary HabitsLifestyle Intervention+1
RECRUITINGPhase 2NCT06494995

AK104 and Low-dose Radiation in Recurrent/Metastatic HNSCC After Failure of First-line Systemic Therapy

Currently, there is a lack of high-quality clinical evidence for subsequent treatment options for recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) after...

Sponsor: Fudan UniversityEnrolling: 521 location
Head and Neck Squamous Cell Carcinoma
RECRUITINGNCT07278700

The Fever Clinic Acute Respiratory Cohort

This prospective cohort study aims to characterize the natural progression and outcomes of acute respiratory infections among patients presenting to fever clinics. At enrollment,...

Sponsor: Fudan UniversityEnrolling: 10001 location
Acute Respiratory InfectionsFebrile IllnessesCommunity-acquired Pneumonia+2